BridgeMD

Sign in

Cardioversion clinical trials

Explore recruiting cardioversion clinical trials.

Recruiting cardioversion studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cardioversion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RECURrence of Atrial Fibrillation after cardioversion of patients randomized to open-label treatment with dapagliflozin or usual care (RECUR-AF)

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

Effect of H2 inhalation therapy on early recurrence after atrial fibrillation ablation. Multicenter, open-label, randomized phase II controlled trial.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

"Multicenter randomized clinical trial to evaluate the cardioverter capacity of amiodarone pre-electrical cardioversion in persistent atrial fibrillation"

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A perspective multicenter randomized clinical trial for the safety and efficacy of flecainide compared to amiodorone for the conversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary disease without residual ischemia and ejection fraction >35% (FLECA-ED)

Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open-label, randomized clinical trial comparing Etacizin versus Propafenone in Atrial Fibrillation

Latvia

Therapeutic use (Phase IV) EU CTIS Study details

Multicenter randomized clinical trial to evaluate two different amiodarone regimens to maintain sinus rhythm after cardioversion in persistent atrial fibrillation (PERIVERSION-2).

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Cardioversion trials by city

Cardioversion in Toronto Cardioversion in Vancouver Cardioversion in Montreal Cardioversion in Calgary Cardioversion in Edmonton Cardioversion in Ottawa Cardioversion in Winnipeg Cardioversion in Quebec City Cardioversion in Hamilton Cardioversion in Kitchener Cardioversion in London Cardioversion in Halifax Cardioversion in New York Cardioversion in Los Angeles Cardioversion in Chicago Cardioversion in Houston